AMARIN CORP PLC\UK Increase (Decrease) in Other Operating Liabilities
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Other Operating Liabilities of -$7.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2013-05-09
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for the quarter ending 2013-03-31 was -$7.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for the quarter ending 2012-03-31 was -$8.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for the quarter ending 2011-12-31 was $18.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for the quarter ending 2011-09-30 was $11.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for fiscal 2012 was -$50.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for fiscal 2011 was -$21.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for fiscal 2010 was -$583.00K.
- AMARIN CORP PLC\UK increase (decrease) in other operating liabilities for fiscal 2009 was -$290.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$7.00K 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | -$50.00K 10-K · filed 2013-02-28 | |||
| 2012-03-31 | -$8.00K 10-Q · filed 2013-05-09 | $10.00K derived: sum of 2 quarters · filed 2013-05-09 | $21.00K derived: sum of 3 quarters · filed 2013-05-09 | |
| 2011-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $29.00K derived: sum of 2 quarters · filed 2013-02-28 | -$21.00K 10-K · filed 2013-02-28 | |
| 2011-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$39.00K 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | -$50.00K 10-Q · filed 2011-08-09 | |||
| 2010-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$48.00K derived: sum of 2 quarters · filed 2013-02-28 | -$583.00K 10-K · filed 2013-02-28 | |
| 2010-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$537.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$535.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | -$290.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |